We investigated the possibility of continuously recording the process of clot lysis with a thermometric clot detec-tor. Experiments in which fibrinolytic activators and in-hibitors were used demonstrate that the detection sys-tem, without any mechanical modifications, is suitable for monitoring the complete coagulation process from clot formation to the ultimate lysis of the clot itself. Additional Keyphrases: fibrinolysis #{149}streptokinase thera-py #{149}clot lysis inhibition #{149}thermistor Currently, the study of fibrinolysis is beset by problems of methodology (1). Disadvantages of many of the present methods for measurement of clot lysis-including lysis time for the dilute blood clot, throm-boelastography, euglobulin clot lysis, fib...
The objective of this work was to develop a high throughput assay for testing in vitro the thromboly...
The objective of this work was to develop a high throughput assay for testing in vitro the thromboly...
INTRODUCTION: Hemolysate in plasma samples from patients may cause misleading results in coagulation...
Abstract Background Determination of clot lysis times on whole blood, diluted whole blood, plasma or...
Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has...
A clot lysis time assay in which a tissue factor—induced fibrin clot is lysed by exogenously added t...
<p>A typical fibrinolysis monitoring<b>.</b> Euglobulin Clot Lysis Time (ECLT) is expressed in minut...
SUMMARY A simple screening method for determining the fibrinolytic activity of plasma is de-scribed....
A novel and precise assay that facilitates high-throughput screening of fibrinolytic agents was deve...
SYNOPSIS Natural or spontaneous fibrinolytic activity of the blood is due to a labile activator whic...
Abstract Background Thrombolytic drugs are widely used for the management of cerebral venous sinus t...
Copyright © 2014 Abuzar Elnager et al.This is an open access article distributed under the Creative ...
A photoelectric clot timer is described. The apparatus allows a large analytic capacity, with good p...
Thrombosis is a leading contributor to death and disability, carrying high social and healthcare cos...
The objective of this work was to develop a high throughput assay for testing in vitro the thromboly...
The objective of this work was to develop a high throughput assay for testing in vitro the thromboly...
The objective of this work was to develop a high throughput assay for testing in vitro the thromboly...
INTRODUCTION: Hemolysate in plasma samples from patients may cause misleading results in coagulation...
Abstract Background Determination of clot lysis times on whole blood, diluted whole blood, plasma or...
Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has...
A clot lysis time assay in which a tissue factor—induced fibrin clot is lysed by exogenously added t...
<p>A typical fibrinolysis monitoring<b>.</b> Euglobulin Clot Lysis Time (ECLT) is expressed in minut...
SUMMARY A simple screening method for determining the fibrinolytic activity of plasma is de-scribed....
A novel and precise assay that facilitates high-throughput screening of fibrinolytic agents was deve...
SYNOPSIS Natural or spontaneous fibrinolytic activity of the blood is due to a labile activator whic...
Abstract Background Thrombolytic drugs are widely used for the management of cerebral venous sinus t...
Copyright © 2014 Abuzar Elnager et al.This is an open access article distributed under the Creative ...
A photoelectric clot timer is described. The apparatus allows a large analytic capacity, with good p...
Thrombosis is a leading contributor to death and disability, carrying high social and healthcare cos...
The objective of this work was to develop a high throughput assay for testing in vitro the thromboly...
The objective of this work was to develop a high throughput assay for testing in vitro the thromboly...
The objective of this work was to develop a high throughput assay for testing in vitro the thromboly...
INTRODUCTION: Hemolysate in plasma samples from patients may cause misleading results in coagulation...